Home / Metformin and Sitagliptin / Czechia
CZ ATC A10BD07 · updated 2 Nov 2026
Metformin and Sitagliptin shortage in Czechia
Is there a Metformin and Sitagliptin shortage in Czechia?
Yes. As of 2 Nov 2026, 9 Metformin and Sitagliptin products are reported short in Czechia, the first since 18 Mar 2025. The company estimate for the return is 30 Nov 2026 (latest 31 Oct 2027). Main reason: commercial decision or withdrawal.
Also short in Canada, Italy. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | SITAGLIPTIN/METFORMIN TEVA 50MG/1000MG 50MG/1000MG TBL FLM 56 | Teva Pharmaceuticals CR, s.r.o., Praha | 18 Mar 2025 | 31 Oct 2027 | Manufacturing problem Výrobní důvody |
| CZ | SITAGLIPTIN/METFORMIN TEVA 50MG/850MG 50MG/850MG TBL FLM 56 | Teva Pharmaceuticals CR, s.r.o., Praha | 12 May 2025 | 31 Oct 2027 | Distribution or logistics Kapacitní/distribuční důvody |
| CZ | JAMESI 50MG/1000MG 50MG/1000MG TBL FLM 196 | VIATRIS LIMITED, Dublin | 22 Aug 2025 | not given | Other opožděný switch na Jamesi Novum SUKL: 271203 |
| CZ | SITAGLIPTIN/METFORMIN GRINDEKS 50MG/1000MG 50MG/1000MG TBL FLM 196(2X98) | AS GRINDEKS, Riga | 31 Dec 2025 | 1 Jan 2027 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | SITAGLIPTIN/METFORMIN GRINDEKS 50MG/1000MG 50MG/1000MG TBL FLM 56 | AS GRINDEKS, Riga | 31 Dec 2025 | 1 Jan 2027 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | SITAGLIPTIN/METFORMIN GRINDEKS 50MG/850MG 50MG/850MG TBL FLM 56 | AS GRINDEKS, Riga | 31 Dec 2025 | 1 Jan 2027 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | JANSITIN DUO 50MG/850MG 50MG/850MG TBL FLM 56 | G.L. Pharma GmbH, Lannach | 26 Mar 2026 | 1 Apr 2027 | Manufacturing problem Výrobní důvody |
| CZ | SIPACTIMET 50MG/1000MG 50MG/1000MG TBL FLM 196 II | Heaton k.s., Praha | 1 Oct 2026 | 30 Jun 2027 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | SITAGLIPTIN/METFORMIN TEVA 50MG/1000MG 50MG/1000MG TBL FLM 98 | Teva Pharmaceuticals CR, s.r.o., Praha | 12 Oct 2026 | 30 Nov 2026 | Manufacturing problem Výrobní důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.